NCT02415595 - Dose-finding Study of BMS-955176 to Treat HIV-1 Infected Treatment-naive Adults | Biotech Hunter

Enrollment

210

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

May 26, 2016

Study Completion Date

August 21, 2017

Conditions

Infection, Human Immunodeficiency Virus

Interventions

DRUG

BMS-955176

HIV Maturation Inhibitor

DRUG

EFV

DRUG

TDF/FTC

Trial Locations (64)

1141

GSK Investigational Site, Buenos Aires

1202

GSK Investigational Site, Buenos Aires

2000

GSK Investigational Site, Rosario

9301

GSK Investigational Site, Bloemfontein

12157

GSK Investigational Site, Berlin

13353

GSK Investigational Site, Berlin

14000

GSK Investigational Site, DF

15706

GSK Investigational Site, Santiago de Compostela

20020

GSK Investigational Site, Fracc. Las Americas

20127

GSK Investigational Site, Milan

20157

GSK Investigational Site, Milan

20900

GSK Investigational Site, Monza

24127

GSK Investigational Site, Bergamo

28034

GSK Investigational Site, Madrid

28040

GSK Investigational Site, Madrid

28805

GSK Investigational Site, Alcalá de Henares

30033

GSK Investigational Site, Decatur

30312

GSK Investigational Site, Atlanta

30625

GSK Investigational Site, Hanover

32720

GSK Investigational Site, DeLand

34000

GSK Investigational Site, Durango

37000

GSK Investigational Site, León

40225

GSK Investigational Site, Düsseldorf

44093

GSK Investigational Site, Nantes

44137

GSK Investigational Site, Dortmund

45122

GSK Investigational Site, Essen

53127

GSK Investigational Site, Bonn

69317

GSK Investigational Site, Lyon

74135

GSK Investigational Site, Tulsa

75012

GSK Investigational Site, Paris

75013

GSK Investigational Site, Paris

75475

GSK Investigational Site, Paris

76104

GSK Investigational Site, Fort Worth

80335

GSK Investigational Site, Munich

80336

GSK Investigational Site, Munich

87505

GSK Investigational Site, Santa Fe

90036

GSK Investigational Site, Los Angeles

90211

GSK Investigational Site, Beverly Hills

94276

GSK Investigational Site, Le Kremlin-Bicêtre

7560994

GSK Investigational Site, Santiago

8360159

GSK Investigational Site, Santiago

C1181ACH

GSK Investigational Site, Ciudad Autonoma de Buenos Aires

X5000JJS

GSK Investigational Site, Córdoba

T6G 2G3

GSK Investigational Site, Edmonton

R3A 1R9

GSK Investigational Site, Winnipeg

K1H 8L6

GSK Investigational Site, Ottawa

H2L 4P9

GSK Investigational Site, Montreal

H2L 5B1

GSK Investigational Site, Montreal

H3A 1T1

GSK Investigational Site, Montreal

H4A 3J1

GSK Investigational Site, Montreal

G1V 4G2

GSK Investigational Site, Québec

Unknown

GSK Investigational Site, Santiago

06202

GSK Investigational Site, Nice

CP 14080

GSK Investigational Site, Mexico City

85-030

GSK Investigational Site, Bydgoszcz

71-252

GSK Investigational Site, Szczecin

01-201

GSK Investigational Site, Warsaw

50-220

GSK Investigational Site, Wroclaw

08916

GSK Investigational Site, Badalona

EH4 2XU

GSK Investigational Site, Edinburgh

E1 1BB

GSK Investigational Site, London

SW10 9NH

GSK Investigational Site, London

W2 1NY

GSK Investigational Site, London

SW17 0QT

GSK Investigational Site, Tooting, London